These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33078997)

  • 1. Fractal Analysis: Prognostic Value of Left Ventricular Trabecular Complexity Cardiovascular MRI in Participants with Hypertrophic Cardiomyopathy.
    Wang J; Li Y; Yang F; Bravo L; Wan K; Xu Y; Cheng W; Sun J; Zhu Y; Zhu T; Gkoutos GV; Han Y; Chen Y
    Radiology; 2021 Jan; 298(1):71-79. PubMed ID: 33078997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of athlete's heart and hypertrophic cardiomyopathy by the fractal dimension of left ventricular trabeculae.
    Vilades D; Garcia-Moll X; Gomez-Llorente M; Pujadas S; Ferrero-Gregori A; Doñate T; Mirabet S; Leta R; Pons-Lladó G; Carreras F; Cinca J
    Int J Cardiol; 2021 May; 330():232-237. PubMed ID: 33621621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal cardiac formation in hypertrophic cardiomyopathy: fractal analysis of trabeculae and preclinical gene expression.
    Captur G; Lopes LR; Patel V; Li C; Bassett P; Syrris P; Sado DM; Maestrini V; Mohun TJ; McKenna WJ; Muthurangu V; Elliott PM; Moon JC
    Circ Cardiovasc Genet; 2014 Jun; 7(3):241-8. PubMed ID: 24704860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.
    Vigneault DM; Yang E; Jensen PJ; Tee MW; Farhad H; Chu L; Noble JA; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Ho CY; Bluemke DA
    Radiology; 2019 Mar; 290(3):640-648. PubMed ID: 30561279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of apical cavity obliteration in apical hypertrophic cardiomyopathy.
    Kim H; Park JH; Won KB; Yoon HJ; Park HS; Cho YK; Nam CW; Han S; Hur SH; Kim YN; Kim KB
    Heart; 2016 Aug; 102(15):1215-20. PubMed ID: 26969633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
    Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
    [No Abstract]   [Full Text] [Related]  

  • 8. Left Atrial Function Predicts Outcome in Dilated Cardiomyopathy: Fast Long-Axis Strain Analysis Derived from MRI.
    Li Y; Xu Y; Tang S; Jiang X; Li W; Guo J; Yang F; Xu Z; Sun J; Han Y; Zhu Y; Chen Y
    Radiology; 2022 Jan; 302(1):72-81. PubMed ID: 34698565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractal Analysis of Right Ventricular Trabeculae in Pulmonary Hypertension.
    Dawes TJW; Cai J; Quinlan M; de Marvao A; Ostrowski PJ; Tokarczuk PF; Watson GMJ; Wharton J; Howard LSGE; Gibbs JSR; Cook SA; Wilkins MR; O'Regan DP
    Radiology; 2018 Aug; 288(2):386-395. PubMed ID: 29869959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between left ventricular fractal dimension and impaired strain assessed by cardiac MRI feature tracking in patients with left ventricular noncompaction and normal left ventricular ejection fraction.
    Yu S; Chen X; Yang K; Wang J; Zhao K; Dong W; Yan W; Su G; Zhao S
    Eur Radiol; 2022 Apr; 32(4):2594-2603. PubMed ID: 34779872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
    J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial perfusion abnormality in the area of ventricular septum-free wall junction and cardiovascular events in nonobstructive hypertrophic cardiomyopathy.
    Kaimoto S; Kawasaki T; Kuribayashi T; Yamano M; Miki S; Kamitani T; Matsubara H
    Int J Cardiovasc Imaging; 2012 Oct; 28(7):1829-39. PubMed ID: 22187199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of Cardiac Magnetic Resonance Fractal Analysis Combined With Myocardial Strain in Discriminating Isolated Left Ventricular Noncompaction and Dilated Cardiomyopathy.
    Zheng T; Ma X; Li S; Ueda T; Wang Z; Lu A; Zhou W; Zou H; Zhao L; Gong L
    J Magn Reson Imaging; 2019 Jul; 50(1):153-163. PubMed ID: 30565346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of left ventricular trabeculae using fractal analysis.
    Captur G; Muthurangu V; Cook C; Flett AS; Wilson R; Barison A; Sado DM; Anderson S; McKenna WJ; Mohun TJ; Elliott PM; Moon JC
    J Cardiovasc Magn Reson; 2013 May; 15(1):36. PubMed ID: 23663522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of standardized reference values for speckle-tracking global longitudinal strain in hypertrophic cardiomyopathy.
    Hartlage GR; Kim JH; Strickland PT; Cheng AC; Ghasemzadeh N; Pernetz MA; Clements SD; Williams BR
    Int J Cardiovasc Imaging; 2015 Mar; 31(3):557-65. PubMed ID: 25585646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased fractal dimension of left ventricular trabeculations is associated with subclinical diastolic dysfunction in patients with type-2 diabetes mellitus.
    Shang Y; Zhang X; Leng W; Lei X; Chen L; Zhou X; Chow K; Shi Y; Dong J; Liang Z; Wang J
    Int J Cardiovasc Imaging; 2019 Apr; 35(4):665-673. PubMed ID: 30430327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction.
    Xu J; Zhuang B; Sirajuddin A; Li S; Huang J; Yin G; Song L; Jiang Y; Zhao S; Lu M
    Radiology; 2020 Feb; 294(2):275-286. PubMed ID: 31769741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.
    Cheng S; Choe YH; Ota H; Cui C; Yin G; Lu M; Li L; Chen X; Prasad SK; Zhao S
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):597-605. PubMed ID: 29071521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry.
    Marstrand P; Han L; Day SM; Olivotto I; Ashley EA; Michels M; Pereira AC; Wittekind SG; Helms A; Saberi S; Jacoby D; Ware JS; Colan SD; Semsarian C; Ingles J; Lakdawala NK; Ho CY;
    Circulation; 2020 Apr; 141(17):1371-1383. PubMed ID: 32228044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.